OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date
Marzieh Nikoo, Fatemeh Rabiee, Hossein Mohebbi, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109881-109881
Closed Access | Times Cited: 17
Marzieh Nikoo, Fatemeh Rabiee, Hossein Mohebbi, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109881-109881
Closed Access | Times Cited: 17
Showing 17 citing articles:
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 56
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 56
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
Hung‐Yang Kuo, Kabir A. Khan, Robert S. Kerbel
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 468-482
Closed Access | Times Cited: 29
Hung‐Yang Kuo, Kabir A. Khan, Robert S. Kerbel
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 468-482
Closed Access | Times Cited: 29
High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome
Nithya Krishnamurthy, Daisuke Nishizaki, Scott M. Lippman, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 9
Nithya Krishnamurthy, Daisuke Nishizaki, Scott M. Lippman, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 9
Mathematical modeling of interactions between colon cancer and immune system with a deep learning algorithm
Elham Raeisi, Mehmet Yavuz, Mohammadreza Khosravifarsani, et al.
The European Physical Journal Plus (2024) Vol. 139, Iss. 4
Open Access | Times Cited: 9
Elham Raeisi, Mehmet Yavuz, Mohammadreza Khosravifarsani, et al.
The European Physical Journal Plus (2024) Vol. 139, Iss. 4
Open Access | Times Cited: 9
Advances in adoptive T-cell therapy for metastatic melanoma
Aparimita Das, Aruni Ghose, Kevin Naicker, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 3, pp. 103404-103404
Closed Access | Times Cited: 21
Aparimita Das, Aruni Ghose, Kevin Naicker, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 3, pp. 103404-103404
Closed Access | Times Cited: 21
Metastasis organotropism in colorectal cancer: advancing toward innovative therapies
Kai He, Zhihan Wang, Maochao Luo, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Kai He, Zhihan Wang, Maochao Luo, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Advances in immunotherapy for breast cancer and feline mammary carcinoma: From molecular basis to novel therapeutic targets
Tatiana Vilela, Sofia Valente, Jorge Correia, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189144-189144
Open Access | Times Cited: 5
Tatiana Vilela, Sofia Valente, Jorge Correia, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189144-189144
Open Access | Times Cited: 5
Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Microenvironment-based immunotherapy in oral cancer: a comprehensive review
Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Masumeh Ghazanfarpour, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Masumeh Ghazanfarpour, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer
Walid Shalata, Alexander Yakobson, Yulia Dudnik, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2438-2438
Open Access | Times Cited: 6
Walid Shalata, Alexander Yakobson, Yulia Dudnik, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2438-2438
Open Access | Times Cited: 6
Single-cell and bulk RNA sequencing analysis of B cell marker genes in TNBC TME landscape and immunotherapy
Fangrui Zhao, Chen Zhao, Tangpeng Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Fangrui Zhao, Chen Zhao, Tangpeng Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy
Marzieh Nikoo, Zahraa F. Hassan, Mahsa Mardasi, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154473-154473
Closed Access | Times Cited: 5
Marzieh Nikoo, Zahraa F. Hassan, Mahsa Mardasi, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154473-154473
Closed Access | Times Cited: 5
Uncommon Adverse Events of Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Systematic Review of Case Reports
Eunso Lee, Jeong Yun Jang, Jinho Yang
Cancers (2024) Vol. 16, Iss. 10, pp. 1896-1896
Open Access | Times Cited: 1
Eunso Lee, Jeong Yun Jang, Jinho Yang
Cancers (2024) Vol. 16, Iss. 10, pp. 1896-1896
Open Access | Times Cited: 1
Molecular targets for metastasis-directed therapy in malignant tumors
Vitalina Bodenko, M. S. Larkina, A. A. Prach, et al.
Bulletin of Siberian Medicine (2024) Vol. 23, Iss. 2, pp. 101-113
Open Access
Vitalina Bodenko, M. S. Larkina, A. A. Prach, et al.
Bulletin of Siberian Medicine (2024) Vol. 23, Iss. 2, pp. 101-113
Open Access
Combined Immune Therapy Proves Effective in an Advanced Hepatocellular Carcinoma Patient With Poor Liver Reserve: A Case Report
Hisashi Nagai, Hao Chen, Ryusuke Karube, et al.
Cureus (2024)
Open Access
Hisashi Nagai, Hao Chen, Ryusuke Karube, et al.
Cureus (2024)
Open Access
Genomic and Transcriptomic Characteristics of Tumors of Patients with Metastatic Clear Cell Renal Cell Carcinoma Clinically Benefiting from First-Line Treatment with Ipilimumab Plus Nivolumab
Nishita Tripathi, Luís Meza, Nicolas Sayegh, et al.
Kidney Cancer (2023) Vol. 7, Iss. 1, pp. 137-145
Open Access
Nishita Tripathi, Luís Meza, Nicolas Sayegh, et al.
Kidney Cancer (2023) Vol. 7, Iss. 1, pp. 137-145
Open Access
